Demystifying market entry into the USA: What steps to take to successfully navigate the US healthcare market. More than ever, healthcare plays a critical role in the United States. But what does this mean for providers of medical technology products or solutions in Baden-Württemberg?[...]
BioPortUSA is extremely excited to announce the addition of two new clients who are both involved in the fight against Covid-19.[...]
MAP BioPharma is a U.K. based life science consultancy that works with several partners who share their vision to accelerate patient access and support Pharmaceutical and MedTech companies in reaching patients sooner with their medicines, devices, and diagnostics. Christian Hill, CEO & Co-Founder of MAP BioPharma says that “BioPortUSA facilitates entry for overseas-life sciences companies into the United States so are a natural fit and addition to MAP’s network and we look forward to working with them to support our clients”. MAP BioPharm’s extensive knowledge of the European healthcare environment provides strategic guidance for successful European Market entry. Operating in a diverse market requires careful consideration. Their team will guide you through the necessary steps and provide a blueprint to ensure that you have covered all the requirements for the European Market. Christian has built a solid company, with an incredible network that will no doubt benefit our clients who are looking to go overseas. We in turn look forward to supporting MAPBioPharma clients who are looking to gain entry into the USA’’ says CEO & Founder Mark Lesselroth. [...]
European Medical Market Access Network (EUMMAN) has invited BioPortUSA to present a webinar on market entry USA to their clients on Monday, June 8th, 2020. Mark Lesselroth, CEO of BioPort will talk about what it takes to be successful in the U.S. Healthcare market and what steps one should take before considering entering the market.[...]
BioPortUSA has been invited to present to a group of Danish medtech start-ups on Thursday, May 21st on market entry USA. The focal point will be on how these companies can access the market efficiently and successfully by reviewing a step-process BioPort has developed.[...]
Teicos Pharma (www.teicospharma.com) is a Finish based Pharmaceutical Start-Up whose business is the production and sales of a new class of inhalable API (active pharmaceutical ingredient) powders for dry powder Inhalers (DPI). [...]
BioPortUSA announced today that they have started work with French based Fizimed “We are excited to be working with Fizimed, our first women founded and women owned life sciences client” said Mark Lesselroth, CEO of Bioport.[...]
BioPortUSA is excited to announce that it was recently engaged by Thornhill Medical (www.thornhillmedical.com), to conduct a market landscape for their ClearMate product.[...]
Social Media
